Fig. 3From: Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinomaCellular uptake of C-6-labeled formulations by RAW 264.7 cells: a confocal microscopy images, b flow cytometry, c the statistical results of flow cytometry and and Huh-7 cells: d confocal microscopy images, e flow cytometry, f the statistical results of flow cytometry (n = 3; **p < 0.01)Back to article page